SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    National Health and Medical Research Council. Beam and isotope radiotherapy—A report of the Australian Health Technology Advisory Committee. Publication no. 2036. Canberra: Commonwealth Department of Health and Family Services, 1996.
  • 2
    Statewide Services Development Branch. Radiotherapy management information system. State health publication no.(SSDB) 980139. Sydney: NSW Health Department, 1997.
  • 3
    Statewide Services Development Branch. Radiotherapy management information system. State health publication no. (SSDB) 970069. Sydney: NSW Health Department, 1996.
  • 4
    Statewide Services Development Branch. Radiotherapy management information system. State health publication no. (SSDB) 980139. Sydney: NSW Health Department, 1998.
  • 5
    Statewide Services Development Branch. NSW radiotherapy management information system report 2000. Sydney: NSW Health Department, 2001.
  • 6
    Tyldesley S, Boyd C, Shulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001; 49: 973985.
  • 7
    Mackillop WJ, Dixon P, Zhou Y, et al. Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol. 1994; 32: 105115.
  • 8
    Mackillop WJ, Groome PA, Zhang-Solomons J, et al. Does a centralized radiotherapy system provide adequate access in care? J Clin Oncol. 1997; 15: 12611271.
  • 9
    Lote K, Moller T, Nordman E, et al. Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987. Acta Oncol. 1991; 30: 555561.
  • 10
    Denham JW. How do we bring an acceptable level of radiotherapy services to a dispersed population? Australas Radiol. 1995; 39: 171173.
  • 11
    Barton MB. Radiotherapy utilisation in New South Wales from 1996 to 1998. Australas Radiol. 2000; 44: 483484.
  • 12
    Delaney G, Barton B, Jacob S. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer. 2003; 98: 19771986.
  • 13
    Delaney G, Barton M, Jacob S, Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 2003; 4: 120128.
  • 14
    Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma. A review of the evidence. Cancer. 2004; 100: 12931301.
  • 15
    Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal cancer: A review of the evidence. Cancer. 2004; 101: 657670.
  • 16
    Delaney G, Jacob S, Barton M. Estimating the optimal external beam radiotherapy utilization rate for genitourinary malignancies. Cancer. 2005; 103: 462473.
  • 17
    Delaney G, Jacob S, Barton M. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma. Cancer. 2005; 103: 22162227.
  • 18
    Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic cancer: part I-malignancies of the cervix, ovary, vagina, and vulva. Cancer. 2004; 101: 671681.
  • 19
    Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic cancer: part II-carcinoma of the endometrium. Cancer. 2004; 101: 682692.
  • 20
    Featherstone C, Delaney G, Jacob S, Barton M. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I-lymphoma. Cancer. 2005; 103: 383392.
  • 21
    Featherstone C, Delaney G, Jacob S, Barton M. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myeloma. Cancer. 2005; 103: 393401.
  • 22
    Delaney G, Jacob S, Barton M. Estimating the optimal radiotherapy utilization for cancer of the central nervous system, thyroid cancer, and cancer of unknown primary origin from evidence-based clinical guidelines. Cancer. 2005;in press.
  • 23
    National Health and Medical Research Council. Guide to the development, implementation and evaluation of clinical practice guidelines. Appendix B, 56. Canberra: National Health and Medical Research Council. 1998.
  • 24
    Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys. 2002; 53: 12401253.
  • 25
    Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys. 2003; 56: 12951307.
  • 26
    Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys. 2003; 55: 5163.
  • 27
    Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 1998. CAN 12. Cancer Series No 17. Canberra: AIHW and AACR, 2001.
  • 28
    National Comprehensive Cancer Network. National practice guidelines in oncology-breast cancer. Version 2. Available from URL: www.nccn.org. 2002. [Accessed February 21, 2003].
  • 29
    National Cancer Institute. PDQ cancer information summaries: Treatment of breast cancer. Available from URL: www.nci.nih.gov. 2003. [Accessed February21, 2003].
  • 30
    NHMRC National Breast Cancer Centre. Clinical practice guidelines for the management of advanced breast cancer. National Health and Medical Research Council. Kings Cross: NHMRC National Breast Cancer Centre, 2001.
  • 31
    Moller TR, Brorsson B, Ceberg J, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol. 2003; 42: 387410.
  • 32
    National Cancer Institute (Cancer Statistics Branch). SEER Stat 5.0. Surveillance, Epidemiology and End Results cancer incidence public-use database, 1973–2000. Bethesda: US Department of Health and Human Services. 2002.
  • 33
    American College of Surgeons. National Cancer Database. Available from URL: http://www.facs.org.dept/cancer/ncdb/whatsncdb.html [accessed on November 25, 2003].
  • 34
    Northern and Yorkshire Cancer Registry and Information Service (NYCRIS). Northern and Yorkshire Cancer Networks. A report on incidence and management for the main sites of cancer 1999. Available from URL: http://www.nycris.org.uk/. 2002. [Accessed on November 25, 2003].
  • 35
    Hill D, Jamrozik K, White V, Collins J, et al. Surgical Management of Breast Cancer in Australia in 1995. Kings Cross, NHMRC National Breast Cancer Centre, 1999.
  • 36
    Clinical Governance Unit. The National Colorectal Cancer Care Survey. Australian clinical practice in 2000. Melbourne: National Cancer Control Initiative. 2002.
  • 37
    Hill DJ, White VM, Giles GG, Collins JP, Kitchen PR. Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust. 1994; 161: 110118.
  • 38
    Richardson GE, Thursfield VJ, Giles GG. Reported management of lung cancer in Victoria in 1993: comparison with best practice. MJA. 2000; 172: 321324.
  • 39
    Luke C, Chapman P, Priest K, Roder D. Use of radiotherapy in the primary treatment of cancer in South Australia. Australas Radiol. 2003; 47: 161167.
  • 40
    Statewide Services Development Branch. Radiotherapy management information system report 2003. Sydney: NSW Health Department. 2004.
  • 41
    Barton M, Frommer M, Olver I, Cox C, Crowe P, et al. A cancer services framework for Victoria and future directions for the Peter MacCallum Cancer Institute. Available from URL: http://www.health.vic.gov.au/cancer/docs/vcsfinalreport.pdf. 2003. [Accessed January 10, 2005].